Capsugel has announced the addition of an Xcelodose 600S filling machine for micro-dosing of powders into capsules at its facility in Edinburgh, Scotland.
Capsugel was acquired by Lonza earlier this year.
The Edinburgh facility’s Site Head Jane Fraser said, “We are pleased to add API-in-capsule micro-dosing services to our clinical services offering at our Edinburgh facility. By adding new Xcelodose-based micro-dosing capabilities to our traditional liquid-filled hard capsule technology and high-potency capabilities, we are providing our customers with industry-leading solutions for rapid feasibility assessments and early stage clinical evaluations for their drug pipelines.”
Read the Capsugel press release.
